AB126 / Aruna Bio - LARVOL DELTA

Aruna Bio Announces Issuance of U.S. Patent for Method of Use for Neural Exosomes Used to Reduce Inflammation in the Brain (GlobeNewswire) - "Aruna Bio, Inc...today announced that the U.S. Patent and Trademark Office has allowed U.S. Patent Application No. 17/238760, entitled Neural Cell Extracellular Vesicles, with method of use claims pertaining to its lead program, AB126, for the treatment of neuro-inflammatory diseases. AB126 is an exosome derived from proprietary neural stem cells and has been shown to reduce inflammation in the brain...This patent contains broad claims for the method of using AB126 to treat multiple indications where neuroinflammation is the primary pathological driver of the neurological disease."

Patent • Alzheimer's Disease • CNS Disorders • Parkinson's Disease